Assignee
PHENOMIX CORP
US·7 granted patents·7 pending applications·71 citations·filing 2003–2008
Top patents by PatentIndex Score
14 records- 0192US7576121B2Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IVPHENOMIX CORP·Filed 2006·Granted Aug 18, 2009·15 cites·56 claims
- 0292US7317109B2Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IVPHENOMIX CORP·Filed 2006·Granted Jan 8, 2008·21 cites·27 claims
- 0389US7674913B2Heterocyclic boronic acid compoundsPHENOMIX CORP·Filed 2004·Granted Mar 9, 2010·27 cites·7 claims
- 0480US7884217B2Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IVPHENOMIX CORP·Filed 2007·Granted Feb 8, 2011·3 cites·4 claims
- 0578US7767828B2Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IVPHENOMIX CORP·Filed 2006·Granted Aug 3, 2010·3 cites·31 claims
- 0677US7906658B2Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IVPHENOMIX CORP·Filed 2007·Granted Mar 15, 2011·2 cites·9 claims
- 0748US2010247642A1Stable pharmaceutical formulation for a dpp-iv inhibitorPHENOMIX CORP·Filed 2008·Application pending·0 cites
- 0848US2010323953A1Macrocyclic hepatitis c protease inhibitorsPHENOMIX CORP·Filed 2008·Application pending·0 cites
- 0947US7786312B2Methods of preparing heterocyclic boronic acids and derivatives thereofPHENOMIX CORP·Filed 2006·Granted Aug 31, 2010·0 cites·41 claims
- 1045US2010204484A1Crystalline synthetic intermediate for preparation of a dpp-iv inhibitor and method of purification thereofPHENOMIX CORP·Filed 2008·Application pending·0 cites
- 1145US2010120716A1Macrocyclic hepatitis c serine protease inhibitors and uses thereforPHENOMIX CORP·Filed 2007·Application pending·0 cites
- 1244US2004072228A1Card11 NFkB activating polypeptides, nucleic acids, inbred and transgenic animals, and methods of use thereofPHENOMIX CORP·Filed 2003·Application pending·0 cites
- 1344US2005015821A1Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and usePHENOMIX CORP·Filed 2004·Application pending·0 cites
- 1441US2010087658A1Methods and intermediates for synthesis of selective dpp-iv inhibitorsPHENOMIX CORP·Filed 2008·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →